Fourth, in a previous large study, we found that serum BACE1 activity was able to discriminate AD from a group defined as “other dementia”, including Lewy Body disease, Parkinson’s dementia, FTD, and similar diseases [54]. This evidence concerns the gene BACE1 and frontotemporal dementia.